REGENERON PHARMACEUTICALS, INC. Other Current Liabilities
REGENERON PHARMACEUTICALS, INC. (REGN) had Other Current Liabilities of $122.40 million as of 2020-12-31, per its 10-K filed 2021-02-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2021-02-08
- 2020-12-31: Other Liabilities, Current $122.40M.
- 2020-09-30: Other Liabilities, Current $96.90M.
- 2020-06-30: Other Liabilities, Current $103.80M.
- 2020-03-31: Other Liabilities, Current $85.00M.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2020-12-31 | $122.40M 10-K · filed 2021-02-08 | |
| 2020-09-30 | $96.90M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $103.80M 10-Q · filed 2020-08-05 | |
| 2020-03-31 | $85.00M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $85.00M 10-K · filed 2021-02-08 | |
| 2017-12-31 | $267.00K 10-K · filed 2018-02-08 | |
| 2017-09-30 | $334.00K 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $397.00K 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $876.00K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $1.18M 10-K · filed 2018-02-08 | $3.46M 10-K · filed 2017-02-09 |
| 2016-09-30 | $3.59M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $3.69M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $13.51M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $13.56M 10-K · filed 2017-02-09 | |
| 2015-09-30 | $2.51M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $2.29M 10-Q · filed 2015-08-04 | |
| 2015-03-31 | $2.19M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $97.15M 10-K · filed 2016-02-11 | $96.41M 10-K · filed 2015-02-12 |
| 2013-12-31 | $939.00K 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |